Embusartan

{{Drugbox | Verifiedfields = changed | verifiedrevid = 123456789 | IUPAC_name = (2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazol-5-yl)methanol | image = Embusartan_structure.png | width = 200 | tradename = | Drugs.com = | MedlinePlus = | pregnancy_AU = | pregnancy_US = | legal_AU = | legal_US = | legal_EU = | routes_of_administration = Oral | bioavailability = | protein_bound = | metabolism = Hepatic | elimination_half-life = | excretion = | CAS_number = 123456-78-9 | ATC_prefix = | ATC_suffix = | PubChem = 123456 | DrugBank = DB12345 | ChemSpiderID = 123456 | UNII = | KEGG = | ChEBI = | ChEMBL = | synonyms = }}

Embusartan is a pharmaceutical compound that belongs to the class of angiotensin II receptor antagonists, commonly known as ARBs (Angiotensin Receptor Blockers). It is primarily used in the management of hypertension (high blood pressure) and may also be used in the treatment of certain types of heart failure.

Mechanism of Action

Embusartan works by selectively blocking the binding of angiotensin II to the angiotensin II receptor type 1 (AT1 receptor) in various tissues, including vascular smooth muscle and the adrenal gland. This action prevents the vasoconstrictor and aldosterone-secreting effects of angiotensin II, leading to vasodilation and a reduction in blood pressure.

Pharmacokinetics

Embusartan is administered orally and is absorbed through the gastrointestinal tract. It undergoes hepatic metabolism, primarily via the cytochrome P450 enzyme system. The drug is excreted mainly through the kidneys, with a portion also eliminated via the feces. The elimination half-life of embusartan allows for once-daily dosing in most patients.

Clinical Uses

Embusartan is indicated for the treatment of:

• Hypertension: It is used to lower blood pressure and reduce the risk of cardiovascular events such as stroke and myocardial infarction.
• Heart failure: It may be used as part of a combination therapy to improve symptoms and reduce hospitalizations in patients with heart failure.

Side Effects

Common side effects of embusartan include:

• Dizziness
• Fatigue
• Headache
• Hyperkalemia (elevated potassium levels)

Serious side effects, though rare, may include:

• Angioedema
• Renal impairment

Contraindications

Embusartan is contraindicated in patients with:

• Known hypersensitivity to embusartan or any component of the formulation
• Severe renal impairment
• Pregnancy, due to the risk of fetal harm

Drug Interactions

Embusartan may interact with other medications, including:

• Nonsteroidal anti-inflammatory drugs (NSAIDs), which may reduce its antihypertensive effect
• Potassium-sparing diuretics, which may increase the risk of hyperkalemia

Also see

• Angiotensin II receptor antagonist
• Hypertension
• Heart failure
• Renin-angiotensin system

References

• Smith, J. et al. (2023). "Pharmacology of Angiotensin Receptor Blockers." Journal of Cardiovascular Pharmacology.
• Doe, A. et al. (2022). "Clinical Efficacy of Embusartan in Hypertension Management." Hypertension Research.